Welcome to our dedicated page for KT&G GDR 144A news (Ticker: KTCIY), a resource for investors and traders seeking the latest updates and insights on KT&G GDR 144A stock.
KT&G Corporation (KRX:033780), known for its tobacco, ginseng, and herbal products, has recently faced an ISS recommendation to vote against its Board of Directors' proposals. KT&G expressed concerns about ISS' reliance on data provided by dissident shareholder Flashlight Capital Partners, impacting overseas business performance analysis. Additionally, ISS' recommendations against CEO nominee Kyung-man Bang and other candidates raise questions on CEO selection impartiality and Board-endorsed Outside Candidate director candidacy. KT&G emphasizes rigorous CEO selection processes and inconsistencies between ISS' recommendations and its proxy voting guidelines. Furthermore, discussions between ISS, FCP, and KT&G raised concerns over export business profitability data discrepancies, misinformation, and interactions. KT&G seeks to engage constructively with stakeholders, address concerns, and ensure shareholder value.
Korea Ginseng Corp., the world's leading ginseng brand, partnered with the Coalition for Asian Pacifics in Entertainment (CAPE) to sponsor the Radiance awards event on
KT&G Corporation (OTC-PINK: KTCIY) held its 36th Annual General Meeting of Shareholders on March 28, 2023, in Daejeon, South Korea. All board proposals were approved, including a cash dividend of KRW 5,000 per share. Proposals from some shareholders for higher dividends and amendments to the Articles of Incorporation were rejected. The number of outside directors will remain at six, with reappointments for Kim Myung-chul and Koh Yun-sung. CEO Baek Bok-in emphasized a commitment to enhancing shareholder value through long-term investments and expanding into overseas markets, aiming to establish KT&G as a 'global top-tier' company.
Korea Ginseng Corp. has announced the opening of its new U.S. R&D center, marking a significant step in its strategy to broaden its global health food portfolio. The center will focus on developing products tailored to the American consumer, highlighted by the recent launch of HSW herbal beverages and KORESELECT products. Additionally, the company is enhancing its marketing efforts, appointing actress Arden Cho as the new brand ambassador. With a forecasted growth of the global dietary supplement market to USD 327.4 billion by 2030, Korea Ginseng aims to capitalize on increasing demand for functional foods in the U.S.
Korea Ginseng Corp., the leading ginseng brand globally, has partnered with Hollywood actress Arden Cho to promote its new advertising campaign titled 'The Secret to My Health and Beauty'. Scheduled to launch in mid-March, the campaign aims to boost brand awareness in the U.S. market. The company is expanding its product line with the introduction of HSW, a new range of Korean red ginseng beverages, during New Product Expo West 2023. Korea Ginseng Corp. has established an American R&D center to enhance its position as a prominent health brand in the U.S., building on its legacy since 1899.
Korea Ginseng Corp., the leading ginseng brand, is expanding its Koreselect product line with six new herbal supplements aimed at enhancing mental and physical health. This launch addresses a growing consumer demand for natural wellness solutions, amplified by the COVID-19 pandemic, which has heightened awareness of self-care among younger generations. The new ingredients include Ashwagandha, Elderberry, Beet Root, Milk Thistle, Ginseng, and Probiotics, each with specific health benefits. The push for these supplements reflects changing consumer priorities towards holistic health management.
KGC's red ginseng brand, CheongKwanJang, has been ranked as the number one brand in the global ginseng retail market, boasting a 41.9% market share with sales of approximately USD 1.038 billion in 2022, marking its tenth consecutive year at the top.
The global ginseng retail market was valued at about USD 2.47 billion last year. KGC's sales in Q3 2022 reached KRW 429 billion, showcasing a year-on-year increase.
Korea Ginseng Corp. celebrates its 123rd anniversary by launching a new range of Koreselect online products, focusing on health-oriented gifts for the holiday season. The exclusive online offerings include ashwagandha, elderberry, beet root, milk thistle, American ginseng, and women's probiotics, all aimed at enhancing health and wellbeing. With sales reportedly doubling over the past three years, the company is determined to expand its presence in the U.S. dietary supplement market, which is projected to grow at a CAGR of 8.9% through 2030.
Korea Ginseng Corp. introduces 'Pure Extract Heaven', a premium red ginseng product, to the U.S. market just in time for the holiday season. This top-grade ginseng, comprising only 0.5% of total red ginseng production, highlights the company’s 120 years of expertise. The product is expected to meet the growing demand for herbal supplements in the U.S., where the herbal tea market is projected to reach $5,445.22 million by 2029.
With limited availability, 'Pure Extract Heaven' is poised to become a sought-after luxury gift.
Korea Ginseng Corp. highlights its KORESELECT Immune product, awarded the 2022 Taste For Life Immunity Essential award. This concentrated liquid stick supplement features Korean red ginseng, known for its adaptogenic properties, boosting both acquired and innate immunity. A study from Seoul National University confirms its efficacy against influenza and H1N1 by enhancing immune cell activity. Amidst rising flu activity, KORESELECT aims to support consumers facing the upcoming 'tripledemic.' The KORESELECT line launched in early 2022 and includes five products focusing on health and wellness.
FAQ
What recent recommendation did ISS make about KT&G Corporation's Board of Directors' proposals?
Why did KT&G Corporation express concerns about ISS' recommendation?
What were the concerns raised regarding ISS' recommendations against CEO nominee Kyung-man Bang and other candidates?
What issues were identified in the discussions between ISS, FCP, and KT&G Corporation?